Comparing the current results to its competitors, Lensar Inc reported Revenue increase in the 2 quarter 2026 by 18.37 % year on year. The sales growth was above Lensar Inc 's competitors' average revenue growth of 8.4 %, achieved in the same quarter.
Overall company sales advanced by 18.37 % Lensar Inc outperformed its competitors in this segment and improved market share, to approx. 0.05 %. << More on LNSR Market Share.
*Market share is calculated based on total revenue.
August 8, 2024
LENSAR s Growth Trajectory: Strong Q2 Results Illuminate Bright Future for Cataract Treatments In an era where innovation is crucial to healthcare success, medical technology company LENSAR, Inc. (Nasdaq: LNSR) is making waves with its impressive second-quarter performance. The Orlando-based organization has once again demonstrated its commitment to improving cataract treatment through its advanced laser solutions, particularly with its innovative ALLY System. As it reports financial results and operational updates for the second quarter of 2024, several key details illuminate the company s evolving landscape in the medical technology sector. Solid Growth Fueled by Strategic Advancements LENSAR recently an...
August 7, 2024
ORLANDO, Fla. LENSAR, Inc. (Nasdaq: LNSR), a leading global medical technology company specializing in advanced laser solutions for treating cataracts, has proudly announced that its groundbreaking ALLY Adaptive Cataract Treatment System (ALLY or ALLY System) has been awarded certification under the European Union’s (EU) stringent Medical Device Regulation (MDR). This certification signifies a crucial step forward in ophthalmic technology and opens doors for advanced cataract treatment throughout Europe. Setting New Milestones in Ophthalmic TechnologyThe certification under the EU MDR is no minor feat. Regarded as one of the most comprehensive and rigorous medical device regulatory frameworks globally, ach...
Guided Therapeutics Inc operates on a business model focused on developing and commercializing medical devices for the early detection and monitoring of diseases, with a particular emphasis on cervical cancer.
Escalon Medical Corp is a medical technology company that operates through three segments: ophthalmic diagnostics, ophthalmic surgical and ambulance services. They develop, manufacture and sell a range of medical devices and provide EMS billing services to healthcare providers.
Boston Scientific Corporations business model centers on creating innovative medical devices for diverse specialties, aimed at addressing unmet medical needs and enhancing patient outcomes. The company sells its products to healthcare professionals and hospitals globally, supported by robust sales and distribution networks. It prioritizes research and development to continually introduce new technologies and solutions.
Becton Dickinson and Company operates a business model focused on developing and providing advanced medical technologies, including a diverse portfolio of medical devices and diagnostic products. Their strategy emphasizes innovation, quality, and strategic partnerships to enhance patient care and streamline healthcare processes across various settings.
Sources:
Lensar Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Lensar Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
